Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

The PSLab Android app currently has missing translations across multiple languages in Weblate. While community contributions remain the primary approach for localization, we can improve coverage and ...

Implement a text generation program using a Markov chain language model. The program will "learn" from a corpus of text (like Shakespeare or Darwin) and generate new text in a similar style using ...